Main Article Content
Abstract
Leiomyosarcoma is an extremely aggressive malignant neoplasm associated with an unfavorable overall prognosis for a woman’s life and health. Leiomyosarcoma is mainly a single large formation, located mainly in the myometrium or subserous layer of the uterus. Preoperative diagnosis of sm is difficult, despite the introduction of various diagnostic methods.
There are several cases of leiomyosarcoma in which patients with symptomatic uterine fibroids underwent uterine artery embolization. And one of these rare cases is described in this article. A patient with uterine leiomyoma (confirmed histologically) underwent uterine artery embolization, but given the continued growth of the uterine uterus (rapid growth of nodes), the patient was offered a hysterectomy. Histology results revealed leiomyosarcoma.
Keywords
Article Details
Information about financing and conflict of interests
The authors declare that they have no apparent or potential conflicts of interest related to the publication of this article.
This work is licensed under a Creative Commons Attribution 4.0 License.
How to Cite
References
Prat J. FIGO staging for uterine sarcomas. Int J Gynaecol Obstet. 2009; 104(3): 177-178. DOI: 10.1016/j.ijgo.2008.12.008
Sivova EN, Pachov AI, Bukreev AV, Fokina AP. Some questions of etiology and pathogenesis of endometrial proliferative processes. Siberian Medical Review. 2015; 1: 16-22. Russian (Сивова Е.Н., Пашов А.И., Букреев А.В., Фокина А.П. Некоторые вопросы этиологии и патогенеза пролиферативных процессов эндометрия //Сибирское медицинское обозрение. 2015. № 1. С. 16-22.) DOI: 10.20333/25000136-2015-1-16-22
Momeni-Boroujeni A, Chiang S. Uterine mesenchymal tumours: recent advances. Histopathology. 2020; 76(1): 64-75. DOI: 10.1111/his.14008
Roberts ME, Aynardi JT, Chu CS. Uterine leiomyosarcoma: A review of the literature and update on management options. Gynecol Oncol. 2018; 151(3): 562-572. DOI: 10.1016/j.ygyno.2018.09.010
Liu J, Wang Z. Advances in the Preoperative Identification of Uterine Sarcoma. Cancers (Basel). 2022; 14(14): 3517. DOI: 10.3390/cancers14143517
Żak K, Zaremba B, Rajtak A, Kotarski J, Amant F, Bobiński M. Endometrial Sampling for Preoperative Diagnosis of Uterine Leiomyosarcoma. Cancers (Basel). 2022; 14(8): 1966. DOI: 10.3390/cancers14081966
Kim MD. Uterine Artery Embolization for Leiomyomas and Adenomyosis: A Pictorial Essay Based on Our Experience from 1300 Cases. Korean J Radiol. 2019; 20(10): 1462-1473. DOI: 10.3348/kjr.2019.0205
Papadia A, Salom EM, Fulcheri E, Ragni N. Uterine sarcoma occurring in a premenopausal patient after uterine artery embolization: a case report and review of the literature. Gynecol Oncol. 2007; 104(1): 260-263. DOI: 10.1016/j.ygyno.2006.08.051
Kainsbak J, Hansen ES, Dueholm M. Literature review of outcomes and prevalence and case report of leiomyosarcomas and non-typical uterine smooth muscle leiomyoma tumors treated with uterine artery embolization. Eur J Obstet Gynecol Reprod Biol. 2015; 191: 130-137. DOI: 10.1016/j.ejogrb.2015.05.018
Chung YJ, Kang SY, Chun HJ, Rha SE, Cho HH, Kim JH, Kim MR. Development of a Model for the Prediction of Treatment Response of Uterine Leiomyomas after Uterine Artery Embolization. Int J Med Sci. 2018; 15(14): 1771-1777. DOI: 10.7150/ijms.28687
Tsuji M, Kihara T, Hushimi S, Nishino Y, Kanayama T, Nishijima M. Diagnosis of Leiomyosarcoma after Uterine Artery Embolization for Multiple Leiomyomas. Case Rep Obstet Gynecol. 2020; 2020: 8823428. DOI: 10.1155/2020/8823428